Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity ... on the starting ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

A spokesman said: “We plan to optimise dose titration to further explore CagriSema ... beyond semaglutide [the chemical name for Wegovy], which faces patent expiry at the beginning of the ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating ... don’t go all the way up in the escalation titration dosing of the medication," Sowa said.

Mason acknowledged that, noting that take-up is a "dynamic situation", given the uncertainty of competitor supply, and data on titration rates ... Nordisk's fast-growing Wegovy brand of semaglutide.

Intron Health analysts reportedly suggested that even in a worst-case scenario, CagriSema could generate $8 billion in peak sales — matching Wegovy ... s dose titration and enhance its weight ...

Ozempic, along with its sister drug Wegovy, belongs to a new class of ... Typically, a responsible doctor approaches prescriptions with a titration mindset: starting at a low dose and slowly ...